The International Scientific Advisory Board (ISAB) for the PSCP Hub includes senior academic, industrial and regulatory experts to provide independent advice regarding the Hubs activities and future strategy to ensure scientific excellence. The goal of the ISAB is to steer and challenge the Hub in its development and delivery of our scientific and translational objectives. The PSCP Hubs Advisory Board consist of the following members:
Prof Oliver Brüstle, Institute of Reconstructive Neurobiology, University of Bonn Medical Centre, Germany (ISAB Chair).
Prof Christine Mummery, Department of Anatomy and Embryology, Leiden University Medical Centre, The Netherlands.
Dr Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult, UK.
Dr Steven Howe, Head of Process Research, GlaxoSmithKline, UK.
Ian Rees, Manager for the Inspectorate Strategy and Innovation Unit, MHRA, UK (ISAB Observer)
